Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-040619
Filing Date
2004-03-12
Accepted
2004-03-12 16:50:33
Documents
11
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d10k.htm 10-K 1547823
3 INDENTURE, DATED AS OF MARCH 3, 2004 dex46.htm EX-4.6 534786
4 FORM OF 1 1/2% CONVERTIBLE SENIOR NOTES DUE 2024. dex47.htm EX-4.7 65980
5 REGISTRATION RIGHTS AGREEMENT dex1018.htm EX-10.18 103757
6 SUBSIDIARIES OF IVAX CORPORATION dex21.htm EX-21 31238
7 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1844
8 INFORMATION REGARDING CONSENT OF ARTHUR ANDERSEN LLP dex232.htm EX-23.2 3332
9 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 5829
10 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 5817
11 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4222
12 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4210
  Complete submission text file 0001193125-04-040619.txt   2311900
Mailing Address 4400 BISCAYNE BOULEVARD MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD MIAMI FL 33137 3055756000
IVAX CORP (Filer) CIK: 0000772197 (see all company filings)

EIN.: 161003559 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-09623 | Film No.: 04666671
SIC: 2834 Pharmaceutical Preparations